BBIO logo

BridgeBio Pharma Inc

BBIO

$33.60

- $4.57 (-11.96%) This month

Closed: 22 Feb 2024 21:00 US/Eastern

Key details

CEO

Neil Kumar

Employees

333

Headquarters

Palo Alto, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About BridgeBio Pharma Inc

we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG